Skip to main content
Fig. 1 | Gynecologic Oncology Research and Practice

Fig. 1

From: Analysis of in vitro chemoresponse assays in endometrioid endometrial adenocarcinoma: an observational ancillary analysis

Fig. 1

Distribution of assay results across seven single agent treatments. Patients (n = 64) were categorized based on response to carboplatin, cisplatin, doxorubicin, gemcitabine, paclitaxel, docetaxel, and topotecan. Tumors were either resistant to all drugs (S0), or sensitive (S + I) from anywhere from one (S1) agent to all 7 agents (S7). Sixty percent of grade 1 tumors were pan-sensitive (S7) vs 47.6 and 57.6% of grades 2 and 3

Back to article page

Gynecologic Oncology Research and Practice

ISSN: 2053-6844

Contact us